Drugs / gp160 Vaccine (MicroGeneSys)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00000746 Background | ? → Jul 1994 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gp160 Vaccine (MicroGeneSys) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000746 ↗ |
| Modality | Vaccine | “gp160 Vaccine (MicroGeneSys)” NCT00000746 ↗ |